CEACAM5 and colorectal carcinoma: Secondly, some clinicopathological data was missing or incomplete for a significant proportion of the patients, including information on the adjuvant treatment applied, venous and lymphovascular invasion or preoperative levels of the carcinoembryonic antigen (CEA), a marker used to monitor CRC progression [77, 78].